Corrigendum to “Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer” [Biomaterials 46 (2015) 13–25](S0142961214012782)(10.1016/j.biomaterials.2014.12.028)

Xiao Zhao, Feng Li, Yiye Li, Hai Wang, He Ren, Jing Chen, Guangjun Nie, Jihui Hao

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that in Page-22, Fig. 7E: There were inadvertent duplications of images in the LENP-Gem and ENP-Gem-si-HIF1α groups of Fig. 7E. The corrected images, obtained from original data, should appear as shown below. These changes do not affect the interpretation of data or the conclusion of the study. [Figure presented] The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number121296
JournalBiomaterials
Volume280
DOIs
StatePublished - Jan 2022

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Ceramics and Composites
  • Biomaterials
  • Mechanics of Materials

Fingerprint

Dive into the research topics of 'Corrigendum to “Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer” [Biomaterials 46 (2015) 13–25](S0142961214012782)(10.1016/j.biomaterials.2014.12.028)'. Together they form a unique fingerprint.

Cite this